Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2023

May 15, 2023

SELL
$47.19 - $70.77 $471,900 - $707,700
-10,000 Closed
0 $0
Q3 2022

May 15, 2023

BUY
$31.97 - $49.37 $319,700 - $493,700
10,000 New
10,000 $324,000
Q3 2022

Nov 14, 2022

BUY
$31.97 - $49.37 $319,700 - $493,700
10,000 New
10,000 $325,000
Q1 2020

May 12, 2020

SELL
$37.9 - $104.44 $1.06 Million - $2.91 Million
-27,900 Closed
0 $0
Q4 2019

Feb 11, 2020

SELL
$77.66 - $99.74 $163,086 - $209,454
-2,100 Reduced 7.0%
27,900 $2.58 Million
Q3 2019

Nov 13, 2019

BUY
$90.37 - $122.49 $2.71 Million - $3.67 Million
30,000 New
30,000 $2.71 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Sg3 Management, LLC Portfolio

Follow Sg3 Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg3 Management, LLC with notifications on news.